These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20014535)

  • 21. [Interferon beta-1b. New therapy for patients with secondary progressive multiple sclerosis].
    Nervenarzt; 1999 May; 70(5 Suppl):1-12. PubMed ID: 10368803
    [No Abstract]   [Full Text] [Related]  

  • 22. [The role of interferon beta in the treatment of multiple sclerosis].
    Seeldrayers P
    Rev Med Brux; 1999 Sep; 20(4):A264-7. PubMed ID: 10523902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of relapsing-remitting multiple sclerosis with natural interferon beta: a multicenter, randomized clinical trial.
    Fernández O; Antiquëdad A; Arbizu T; Capdevíla A; de Castro P; Correa de Sa JC; García-Merino JA; Izquierdo G; Magalhaes A; Montalbán X
    Mult Scler; 1995; 1 Suppl 1():S67-9. PubMed ID: 9345404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interferon-beta in multiple sclerosis--who is going to be treated?].
    Aarli JA
    Tidsskr Nor Laegeforen; 1999 Sep; 119(21):3114. PubMed ID: 10522472
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diagnostics and drug therapy of multiple sclerosis].
    Suomen Neurologinen Yhdistys ry
    Duodecim; 2002; 118(13):1411-23. PubMed ID: 12239889
    [No Abstract]   [Full Text] [Related]  

  • 26. The treatment of multiple sclerosis with beta-interferon.
    Poser CM
    Neuroepidemiology; 2008; 31(3):157-8. PubMed ID: 18716413
    [No Abstract]   [Full Text] [Related]  

  • 27. Disease-modifying drugs for the early treatment of multiple sclerosis.
    Flachenecker P
    Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The future looks bright.
    Wende KE
    Rehab Manag; 1999; 12(2):32-4. PubMed ID: 10350900
    [No Abstract]   [Full Text] [Related]  

  • 29. [1/5. Multiple sclerosis].
    Blond B
    Soins; 2008 Oct; (729):61-2. PubMed ID: 18998438
    [No Abstract]   [Full Text] [Related]  

  • 30. Multiple sclerosis to date: diagnosis, epidemiology, new aspects of the pathomechanism and the therapy.
    Bencsik K
    Ideggyogy Sz; 2004 Jan; 57(1-2):41-50. PubMed ID: 15042868
    [No Abstract]   [Full Text] [Related]  

  • 31. [Multiple sclerosis, from the first signs to the diagnostic consultation].
    Papeix C
    Soins; 2009 Nov; (740):36-8. PubMed ID: 20014531
    [No Abstract]   [Full Text] [Related]  

  • 32. [Interferon therapy of multiple sclerosis].
    Jensen D
    Tidsskr Nor Laegeforen; 1999 Sep; 119(21):3142-5. PubMed ID: 10522481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Multiple sclerosis].
    Itoyama Y
    No To Shinkei; 2000 Dec; 52(12):1051-5. PubMed ID: 11193536
    [No Abstract]   [Full Text] [Related]  

  • 34. Optic neuritis.
    Vaphiades MS; Kline LB
    Compr Ophthalmol Update; 2007; 8(2):67-75; discussion 77-8. PubMed ID: 17540123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased intracranial pressure in a case of pediatric multiple sclerosis.
    Williams BJ; Skinner HJ; Maria BL
    J Child Neurol; 2008 Jun; 23(6):699-702. PubMed ID: 18539995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon beta for treatment of multiple sclerosis.
    Wilson BA
    Medsurg Nurs; 1995 Apr; 4(2):151-3. PubMed ID: 7711824
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of multiple sclerosis using recombinant interferon-beta].
    Polman CH; Barkhof F; van Loenen AC; Lucas CJ; Koetsier JC
    Ned Tijdschr Geneeskd; 1994 Jan; 138(1):7-10. PubMed ID: 8289963
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety of serial monthly administration of triple-dose gadopentetate dimeglumine in multiple sclerosis patients: preliminary results of the BECOME trial.
    Wolansky LJ; Haghighi MH; Sevdalis E; Cook SD; Sethi N; Liu J; Joseph G; Tulloch K; Cadavid D
    J Neuroimaging; 2005 Jul; 15(3):289-90. PubMed ID: 15951416
    [No Abstract]   [Full Text] [Related]  

  • 39. How much can we learn from long-term extension trials in multiple sclerosis?
    Noseworthy JH
    Neurology; 2006 Sep; 67(6):930-1. PubMed ID: 17000954
    [No Abstract]   [Full Text] [Related]  

  • 40. [Interferon-beta-1b treatment of disseminated sclerosis].
    Sørensen S
    Ugeskr Laeger; 1997 Feb; 159(6):779-84. PubMed ID: 9045474
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.